FindTrial
Sign In

Fluocinolone Acetonide

DRUG10 trials

Sponsors

Abbvie Deutschland GmbH & Co. KG, Alimera Sciences, Bausch & Lomb Incorporated, Glenn Jaffe, The Cleveland Clinic

Conditions

Age-Related Macular DegenerationAtopic DermatitisDiabetic Macular EdemaMacular EdemaRadiation RetinopathyRetinal Vein OcclusionUveitisUveitis Affecting the Posterior Segment

Phase 1

Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or Panuveitis
CompletedNCT01781936
Glenn JaffeUveitis Affecting the Posterior Segment
Start: 2012-06-30End: 2018-06-13Updated: 2019-12-20

Phase 2

Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema
CompletedNCT00502541
Bausch & Lomb IncorporatedDiabetic Macular Edema
Start: 2001-09-30End: 2006-09-30Updated: 2013-11-28
Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy
TerminatedNCT00695318
Alimera SciencesAge-Related Macular Degeneration
Start: 2008-12-31Updated: 2015-05-29
Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina
TerminatedNCT00770770
Alimera SciencesMacular Edema, Retinal Vein Occlusion
Start: 2009-05-31Updated: 2015-05-28

Phase 3

Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
CompletedNCT00344968
Alimera SciencesDiabetic Macular Edema
Start: 2007-09-30End: 2010-12-31Updated: 2014-05-07
Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
CompletedNCT00344968
Alimera SciencesDiabetic Macular Edema
Start: 2007-09-30End: 2010-12-31Updated: 2014-05-07
Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema
CompletedNCT00490815
Alimera SciencesDiabetic Macular Edema
Start: 2007-08-31End: 2011-04-30Updated: 2014-02-13
Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study
CompletedNCT01304706
Alimera SciencesDiabetic Macular Edema
Start: 2011-04-30Updated: 2015-05-04
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
RecruitingNCT05844982
Jaeb Center for Health ResearchRadiation Retinopathy, Visual Impairment
Start: 2023-11-21End: 2029-12-26Target: 600Updated: 2026-08-20
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Combination with Topical Corticosteroids in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis
Active, not recruitingCTIS2022-502937-24-00
Abbvie Deutschland GmbH & Co. KGAtopic Dermatitis
Start: 2019-01-02Target: 444Updated: 2025-11-07

Unknown Phase

Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant
CompletedNCT04340505
The Cleveland ClinicUveitis
Start: 2019-08-08End: 2026-02-01Updated: 2026-02-05

Related Papers

Comparison of data characterizing the clinical effectiveness of the fluocinolone intravitreal implant (ILUVIEN) in patients with diabetic macular edema from the real world, non-interventional ICE-UK study and the FAME randomized controlled trials
Current Medical Research and Opinion2018-12-2012 citations